A new blood test for the early detection and prognosis of cancer – Innovation Toronto

Tumor cells circulating in blood are markers for the early detection and prognosis of cancer.

However, detection of these cells is challenging because of their scarcity. In the journal Angewandte Chemie, scientists have now introduced an ultrasensitive method for the direct detection of circulating tumor cells in blood samples. It is based on the amplified, time-resolved fluorescence measurement of luminescent lanthanide ions released from nanoparticles that bind specifically to tumor cells.

Conventional techniques for the detection of circulating tumor cells require complicated enrichment before detection because a sample of 10 million blood cells only contains about one tumor cell. In contrast, the new method developed by a team working with Xiaorong Song, Xueyuan Chen, and Zhuo Chen, at Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian Agriculture and Forestry University, and Fujian Cancer Hospital (Fuzhou, Fujian, China), works with no enrichment step and directly detects circulating tumor cells in blood samples. The technique is based on a so-called “dissolution-enhanced time-resolved photoluminescence” and uses fluorescing nanoparticles made of lanthanide europium complex.

First the researchers produced antibodies against the epithelial cell adhesion molecule (EpCAM, which is a glycoprotein that is present in very high numbers on the surfaces of many tumor cells and acts as a diagnostic marker for cancer). These antibodies were applied as a coating in the wells of microplates, causing tumor cells contained in the blood sample to remain stuck deep in the wells as other blood components were removed.

The scientists coated the europium-containing nanoparticles with the same antibodies. This caused large numbers of the nanoparticles, added in solution, to specifically bind to the tumor cells. A subsequently added “developer” dissolved the nanoparticles, releasing myriad europium ions. These were immediately bound and tightly locked up by other components of the developer solution. This resulted in a manifold amplification of the fluorescence.

Another essential advantage of this method is that europium ions are very long-lived fluorophores that continue to fluoresce for several microseconds after excitation with a flash of light. Because the measurements are time-resolved, it is possible to start the measurement with a delay. Background signals caused by the autofluorescence of cell components only continue for a few nanoseconds and fade before the measurement begins. This increases the sensitivity of the measurements, making it possible for the researchers to detect a single tumor cell per microplate well.

Tests with blood samples from cancer patients registered as few as 10 cells per milliliter of blood. Fourteen out of fifteen cancer patients were correctly identified by this new method. The number of tumor cells in the samples correlated strongly with the stage of cancer in each patient.

Learn more: Direct detection of circulating tumor cells in blood samples

August 8, 2019 – DNA blood test may help determine success of breast cancer treatment  UPI NewsDNA from a patient’s breast cancer tumor might help determine whether a treatment is working or not, a new study suggests.

August 7, 2019 – New Super-Sensitive Liquid Biopsy Test For Breast Cancer Described As Possible “Game-Changer”  ForbesA new liquid biopsy test for people with early-stage breast cancer may be able to save some people from invasive surgeries.

August 2, 2019 – Breast cancer blood test detects relapse months before symptoms occur  Medical Device NetworkThe new blood test is able to detect breast cancer DNA circulating in the blood an average of 10.7 months before clinical diagnosis.

August 6, 2019 – Thai researchers develop new blood test for prostate cancer  Medical Device NetworkA research team at Mahidol University has developed a blood test that can detect clinically significant prostate cancer in high-risk patients.

via Google News

The Latest on: Cancer blood test

Could the DNA from a patient’s breast tumor help doctors spot whether stray cancer cells are still in her blood? That’s what a small, new study suggests is possible. If the findings are replicated in … […]

A personalised blood test can tell whether treatments for breast cancer are working, and possibly save people from unnecessary surgery, according to early results. If the test can be validated, it … […]

Doctors have gotten much better at detecting and treating breast cancer early. Drug and chemotherapy regimens to control tumors have gotten so effective, in fact, that in some cases, surgery is no … […]

New DNA Blood Test May Help Guide Breast Cancer Treatment By Serena Gordon HealthDay Reporter THURSDAY, Aug. 8, 2019 (HealthDay News) — Could the DNA from a patient’s breast tumor help doctors spot … […]

Within one week, three patients had been diagnosed with the same rare blood infection. Between June and July of last year, six people being treated at the cancer center in Buffalo … the Pyxis and … […]

A novel blood test is hoped to help track the efficacy of early-stage drug treatments for breast cancer and avoid unnecessary surgical procedures(Credit: rbhavana/Depositphotos) An … […]

A new blood test could be up to 100 times more sensitive at monitoring the progress of early stage breast cancer than existing tests, scientists believe. The targeted digital sequencing (TARDIS) test … […]

A new blood test for tracking breast cancer in patients with early stage disease may enable physicians to more sensitively monitor breast cancer, including looking at responses to treatment, tailoring … […]

Half a dozen cancer patients in New York developed a rare infection after … Although the syringes showed no overt signs of tampering, tests revealed that the medications in the syringes had been … […]

RELATED Test can pinpoint pancreatic cysts that may turn cancerous According to Dr. Sanjay Reddy, a cancer expert unconnected to the USPSTF, “The role of ‘biomarkers,’ or some sort of chemical blood … […]

via  Bing News